Teradyne has delivered a powerful run over the past few years and is heavily linked to testing hardware for artificial intelligence chips, which puts a sharper spotlight on whether the current share price lines up with the cash the business is expected to generate. With the stock now trading around US$265.78 after a volatile few weeks, the question is how much of that AI story is already embedded in its cash flow outlook.
- Over the past 3 years, Teradyne has returned about 194.0%, which makes the current valuation hinge on how durable its future cash flows prove to be.
- Recent broker attention tied to AI computing and semiconductor testing suggests expectations for stronger demand and potentially richer margins, which can shift the timing and scale of cash flows that feed into any intrinsic value estimate.
- What if you looked at Teradyne through its earnings instead? See why Teradyne's 30.2x P/E tells a different valuation story.
The issue now is whether Teradyne's recent price, after that strong multiyear run and AI focused news, is adequately supported by its projected cash flows when viewed through a Discounted Cash Flow (DCF) lens.
If you want more context around Teradyne's AI testing story, it can help to compare it with other robotics and automation plays using the 89 robotics and automation stocks.
Where Does Teradyne Sit on Cash Flow?
The Discounted Cash Flow (DCF) model here evaluates Teradyne based on the cash it can return to shareholders rather than on headlines about AI. Latest twelve month free cash flow sits at about $995.5 million, and the projections used in the model assume that this pool of cash grows over time rather than shrinks.
Those estimates reach into the early 2030s, with free cash flow expected to move above $3b, which points to a business profile that leans on scaling AI chip testing and automation rather than one off spikes. Because the DCF projections put Teradyne's estimated intrinsic value broadly in line with the current share price of $265.78, Jefferies' recent upbeat stance on AI driven demand helps explain why the market is comfortable paying up for that future cash flow stream. Find out what Teradyne could be worth using our Discounted Cash Flow (DCF) estimate.
The Teradyne Narrative: What Would Justify Today's Price?
Narratives pick up where the DCF puzzle leaves off by explaining what would need to happen to Teradyne's growth, margins and earnings for the stock to end up worth meaningfully more or meaningfully less than today, and they sit on Simply Wall St's Community page. Each one turns its view of fair value into a clear thesis about how Teradyne's business might develop so you can watch how that argument holds up over time.
One of the top narratives on Teradyne: 37% undervalued
This Narrative is the analyst consensus Narrative on Simply Wall St, which compiles analysts' consensus price target and revenue and earnings forecasts, not one person's view.
"The main thing that has to go right is Teradyne successfully expanding its role as a dual-vendor tester at large compute and hyperscaler customers while scaling memory and robotics demand..."
Discover why this Narrative puts Teradyne at 37% undervalued.
Teradyne’s price is only one piece of the decision
Valuation tells you what you might be paying for Teradyne, but the research also flags specific risk checks that could matter just as much to your decision. Take a closer look at 1 warning sign before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com